Clinical Trials Directory

Trials / Completed

CompletedNCT02663245

INTEGRA Study: Primary Care Intervention in Type 2 Diabetes Patients With Poor Glycaemic Control

INTEGRA Study: Intervention in Type 2 Diabetes Mellitus Patients With Poor Glycemic Control on Primary Health Care.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
564 (actual)
Sponsor
Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina · Academic / Other
Sex
All
Age
30 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The intensification of the management for the control of glycaemia and other risk factors in patients with type 2 diabetes (DM2) results in a reduction of diabetes-related complications. The strategy to increase the competences of primary care professionals to improve health care has been mainly prompted by the current context of limited resources and restricted access to specialty care. This study aims to evaluate the effectiveness and cost-effectiveness of an integral intervention carried out by primary care professionals with the following components: 1. detection of patients with poor diabetic control; 2. introduction of a specific consultation on diabetes followed by virtual and telephone specialist support; 3. introduction of other measures to overcome patients and professionals barriers to treatment. The main objective of the study is to determine if glycaemic control as measured by the mean concentration of HbA1c of poorly controlled patients improves when these patients are evaluated and treated in primary care under the integral strategy proposed in this study. The INTEGRA project also includes Phase 1 (qualitative research study), which is aimed at identifying viable strategies to suppress barriers to treatment; these strategies have been included to the intervention study (phase 2). Phase 2 is a controlled, quasi-experimental intervention that involves 9 primary care centres of 3 regions (Lleida, Girona, Barcelona). The participants are patients with DM2 with poor glycaemic control that meet all the inclusion criteria and sign the informed consent. The intervention study will have three arms: (1) Control Group; (2) Intervention Group 1 (diabetes specific consultation + additional measures originated in phase 1; and (3) Intervention Group 2 (additional measures originated in phase 1). Phase 1 has been conducted during the last 6 months previous to the initiation of the proposed intervention study and consisted of a qualitative design (individualized interviews with randomly selected patients in each of the participating centers); this qualitative study has contributed to design the final intervention applied on phase 2, particularly, implementing additional measures as coaching sessions to health professionals of the participating centers and automated messaging to patients with reminder and motivational objectives. Phase 2 consists of a recruitment period of 6 months, followed by a 12-month follow-up for each patient

Conditions

Interventions

TypeNameDescription
OTHERIntervention 1* Diabetes specific consultation * Basic training in clinical guidelines * Platform of communication for professionals * Training update to review and evaluate actual cases where the coaching strategy has been applied 2-hours training programme to update and review the training of month 0. * 7-hour training programme in group coaching for primary care professionals with a theoretical and practical approach. * Intervention based on text messaging to patients to remind them of strategies that promote behaviour change in relation to diabetes.
OTHERIntervention 2* 7-hour training programme in group coaching for primary care professionals with a theoretical and practical approach. * Training update to review and evaluate actual cases where the coaching strategy has been applied 2-hour training programme to update and review the training of month 0. * Basic training in clinical guidelines. * Platform of communication for professionals. * Intervention based on text messaging to patients to remind them of strategies that promote behaviour change in relation to diabetes.

Timeline

Start date
2015-12-01
Primary completion
2018-10-31
Completion
2018-12-31
First posted
2016-01-26
Last updated
2019-02-15

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT02663245. Inclusion in this directory is not an endorsement.